| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ester Aso, Víctor Fernández-Dueñas, Marc López-Cano, Jaume Taura, Masahiko Watanabe, Isidre Ferrer, Rafael Luján, Francisco Ciruel. Adenosine A Molecular neurobiology. vol 56. issue 8. 2019-12-12. PMID:30610611. |
adenosine a at present, clinical interest in the plant-derived cannabinoid compound cannabidiol (cbd) is rising exponentially, since it displays multiple therapeutic properties. |
2019-12-12 |
2023-08-13 |
Not clear |
| S Rod Rassek. Urgent need for "EBMM" in pediatric oncology: Evidence based medical marijuana. Pediatric hematology and oncology. vol 36. issue 5. 2019-12-12. PMID:31402734. |
recently, there has been significant media coverage of the efficacy of medical marijuana in the treatment of seizures in children with dravet syndrome, and this has led many to search for other possible pediatric indications for cannabinoids, including many different indications in pediatric cancer. |
2019-12-12 |
2023-08-13 |
Not clear |
| Feten Fekih-Romdhane, Abir Hakiri, Sinda Ben Fadhel, Majda Cheou. [Cannabis use in subjects at ultra high risk for psychosis]. Presse medicale (Paris, France : 1983). vol 48. issue 11 Pt 1. 2019-12-11. PMID:31732360. |
several models have been cited to explain the link between cannabis use and the subsequent onset of psychosis or prepsychotic states: cannabis-induced modifications of some brain structures, a dysregulation of the hypothalamic-pituitary axis and an alteration of normal neurological development via the endocannabinoid system. |
2019-12-11 |
2023-08-13 |
human |
| Jacques D Nguyen, Yanabel Grant, Kevin M Creehan, Candy S Hwang, Sophia A Vandewater, Kim D Janda, Maury Cole, Michael A Taff. Δ Neuropharmacology. vol 151. 2019-12-10. PMID:30980837. |
medical cannabis ("medical marijuana") legalization has been associated epidemiologically with reduced opioid harms and cannabinoids have been shown to modulate effects of opioids in animal models. |
2019-12-10 |
2023-08-13 |
Not clear |
| Tiffany N Smith, Anne Walsh, Christopher P Fores. Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. JAAPA : official journal of the American Academy of Physician Assistants. vol 32. issue 4. 2019-12-02. PMID:30913155. |
ironically, chronic use of cannabis can result in paradoxical effects, including a condition known as cannabinoid hyperemesis syndrome. |
2019-12-02 |
2023-08-13 |
Not clear |
| Vincent T Mensen, Annabel Vreeker, Johan Nordgren, Amanda Atkinson, Rafael de la Torre, Magi Farré, Johannes G Ramaekers, Tibor M Brun. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. Psychopharmacology. vol 236. issue 9. 2019-12-02. PMID:30968175. |
psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. |
2019-12-02 |
2023-08-13 |
Not clear |
| Shelby L Blaes, Caitlin A Orsini, Hannah M Holik, Toneisha D Stubbs, Shandera N Ferguson, Sara C Heshmati, Matthew M Bruner, Shannon C Wall, Marcelo Febo, Adriaan W Bruijnzeel, Jennifer L Bizon, Barry Setlo. Enhancing effects of acute exposure to cannabis smoke on working memory performance. Neurobiology of learning and memory. vol 157. 2019-11-25. PMID:30521850. |
almost all of this research has employed cannabinoid injections, however, whereas smoking is the preferred route of cannabis administration in humans. |
2019-11-25 |
2023-08-13 |
rat |
| Shelby L Blaes, Caitlin A Orsini, Hannah M Holik, Toneisha D Stubbs, Shandera N Ferguson, Sara C Heshmati, Matthew M Bruner, Shannon C Wall, Marcelo Febo, Adriaan W Bruijnzeel, Jennifer L Bizon, Barry Setlo. Enhancing effects of acute exposure to cannabis smoke on working memory performance. Neurobiology of learning and memory. vol 157. 2019-11-25. PMID:30521850. |
exposure to placebo smoke had no effect on performance, suggesting that the cannabinoid content of cannabis smoke was critical for its effects on working memory. |
2019-11-25 |
2023-08-13 |
rat |
| Mara Mandrioli, Matilde Tura, Stefano Scotti, Tullia Gallina Tosch. Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in Molecules (Basel, Switzerland). vol 24. issue 11. 2019-11-25. PMID:31167395. |
fast detection of 10 cannabinoids by rp-hplc-uv method in cannabis has regained much attention as a result of updated legislation authorizing many different uses and can be classified on the basis of the content of tetrahydrocannabinol (thc), a psychotropic substance for which there are legal limitations in many countries. |
2019-11-25 |
2023-08-13 |
Not clear |
| Jenny L Wilkerson, David R Schulze, Lance R McMaho. Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments. PloS one. vol 14. issue 3. 2019-11-21. PMID:30861005. |
cannabis withdrawal upon discontinuation of long-term, heavy cannabis use is reported in humans; however, methods to establish the nature and intensity of cannabinoid withdrawal, especially directly observable signs, have not been widely established. |
2019-11-21 |
2023-08-13 |
monkey |
| T.H. Kelly, R.W. Foltin, M.W. Fischma. Effects of smoked marijuana on heart rate, drug ratings and task performance by humans. Behavioural pharmacology. vol 4. issue 2. 2019-11-20. PMID:11224183. |
marijuana puff durations were decreased at the highest dose, but dose-related changes in heart rate and task performance indicated that the change in smoking topography did not result in complete compensation for increased cannabinoid concentrations in marijuana smoke. |
2019-11-20 |
2023-08-12 |
human |
| Vincenzo Di Marzo, Tiziana Bisogno, Luciano De Petrocelli. Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs. Expert opinion on therapeutic targets. vol 5. issue 3. 2019-11-20. PMID:12540270. |
these examples indicate that new therapeutic agents, lacking the undesirable psychotropic side effects of cannabis, may be developed from current studies on the endocannabinoid system. |
2019-11-20 |
2023-08-12 |
Not clear |
| Jayme Cotte. Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review. Oncology nursing forum. vol 36. issue 3. 2019-11-20. PMID:19596652. |
purpose/objectives: to synthesize the research to determine whether oral delta-9-tetrahydrocannabinol (thc) and smoked marijuana are effective treatments for chemotherapy-induced nausea and vomiting (cinv) and to evaluate side effects and patient preference of these treatments.data sources: original research, review articles, and other published articles in cinahl(r), medline(r), and cochrane library databases.data synthesis: cannabinoids are effective in controlling cinv, and oral thc and smoked marijuana have similar efficacy. |
2019-11-20 |
2023-08-12 |
Not clear |
| Wen-Shin Lee, Katalin Erdelyi, Csaba Matyas, Partha Mukhopadhyay, Zoltan V Varga, Lucas Liaudet, György Haskú, Daniela Čiháková, Raphael Mechoulam, Pal Pache. Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation. Molecular medicine (Cambridge, Mass.). vol 22. 2019-11-20. PMID:26772776. |
cannabidiol (cbd) is a nonpsychoactive constituent of marijuana that exerts antiinflammatory effects independent of classical cannabinoid receptors. |
2019-11-20 |
2023-08-13 |
mouse |
| Deepak Cyril D'Souza, Jose A Cortes-Briones, Mohini Ranganathan, Halle Thurnauer, Gina Creatura, Toral Surti, Beata Planeta, Alexander Neumeister, Brian Pittman, Marc Normandin, Michael Kapinos, Jim Ropchan, Yiyun Huang, Richard E Carson, Patrick D Skosni. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis. Biological psychiatry. Cognitive neuroscience and neuroimaging. vol 1. issue 1. 2019-11-20. PMID:26858993. |
the widespread use of cannabis, the increasing legalization of "medical" cannabis, the increasing potency of cannabis and the growing recreational use of synthetic cannabinoid 1 receptor (cb1r) full agonists underscores the importance of elucidating the effects of cannabinoids on the cb1r system. |
2019-11-20 |
2023-08-13 |
human |
| Roberta Ranieri, Daniela Marasco, Maurizio Bifulco, Anna Maria Malfitan. Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders. Recent patents on CNS drug discovery. 2019-11-20. PMID:27334611. |
agents acting via cannabinoid receptors have been widely developed; starting from the chemical structure of phytocannabinoids isolated from cannabis sativa plant, specific and selective compounds of these receptors have been produced ranging from partial to full agonists and /or antagonists endowed with different potency. |
2019-11-20 |
2023-08-13 |
Not clear |
| D S Karhson, A Y Hardan, K J Parke. Endocannabinoid signaling in social functioning: an RDoC perspective. Translational psychiatry. vol 6. issue 9. 2019-11-20. PMID:27676446. |
this article provides a critical review of the major components of the endogenous cannabinoid system (for example, primary receptors and effectors-Δ9-tetrahydrocannabinol, cannabidiol, anandamide and 2-arachidonoylglycerol) and the contributions of cannabinoid signaling to social functioning. |
2019-11-20 |
2023-08-13 |
Not clear |
| Joseph Friedrich, Dara Khatib, Keon Parsa, Ariana Santopietro, G Ian Gallican. The grass isn't always greener: The effects of cannabis on embryological development. BMC pharmacology & toxicology. vol 17. issue 1. 2019-11-20. PMID:27680736. |
furthermore, the use of cannabinoids in cancer treatment via growth inhibition and apoptosis may indicate how cannabis exposure likely harms a growing fetus. |
2019-11-20 |
2023-08-13 |
Not clear |
| David S Mathai, Christopher D Verrico, Daryl Shorter, John H Coverdale, Thomas R Koste. "Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents. The American journal on addictions. vol 25. issue 8. 2019-11-20. PMID:27749024. |
certain medical consequences seem unique to synthetic cannabinoid (sc) and not cannabis use. |
2019-11-20 |
2023-08-13 |
Not clear |
| Susan Audino, Mark Angerhofer, Patricia Atkins, Roger M Brauninger, Paula N Brown, Carolyn Quarles Burdette, Robert Clifford, Jo Marie Cook, Jennifer Donelson, Kevin George, Peter Gibson, Heather L Harris, Thomas Hartlein, George Hodgin, Dorota Inerowicz, Holly E Johnson, George Joseph, Erik J M Konings, Julie A Kowalski, Mary Kay Krogull, Scott Kuzdzal, Robert Lockerman, Cynthia Ludwig, Christina Marrongelli, Katerina Mastovska, Elizabeth Mudge, Gary D Niehaus, Masayuki Nishimura, Melissa Meaney Phillips, Curtis S Phinney, Klaus Reif, Amanda Rigdon, Catherine A Rimmer, Travis Ruthenburg, Aniko M Solyom, Katherine Stenerson, Sidney Sudberg, Alan Sutton, John Szpylka, Jane Weitzel, Paul Winkler, Seth Wong, Joshua Wurzer, Hong You, Scott G Coate. AOAC SMPR® 2017.001. Standard Method Performance Requirements (SMPRs) for Quantitation of Cannabinoids in Cannabis Concentrates. Journal of AOAC International. vol 100. issue 4. 2019-11-20. PMID:28802316. |
standard method performance requirements (smprs) for quantitation of cannabinoids in cannabis concentrates. |
2019-11-20 |
2023-08-13 |
Not clear |